658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC)

Authors:
  • GAGalsky
    Galsky
  • XGX. Guan
    X. Guan
  • RBR. Banchereau
    R. Banchereau
  • LWL. Wang
    L. Wang
  • JZJ. Zhu
    J. Zhu
  • HYH. Yu
    H. Yu
  • DRD. Rishipathak
    D. Rishipathak
  • EHE. Hajaj
    E. Hajaj
  • RHR.H. Herbst
    R.H. Herbst
  • IDI.D. Davis
    I.D. Davis
  • EGE. Grande
    E. Grande
  • ABA. Bamias
    A. Bamias

Abstract
No abstract available
Funding Information
  • F. Hoffmann-La Roche